IQE ($IQE): The Market Just Gave Back a Big Chunk of the AI Photonics Rerating — and I Think That’s a Mistake

Outlier Capital · Outlier Capital · April 25, 2026 at 14:03 · ⏱ 12 min read  | Read on Substack ↗
Summary
Outlier Capital argues that IQE is a strategically important supplier of epitaxial wafers for AI photonics and optical infrastructure, but the market is discounting it due to weak financials. The author views the recent sell-off as a mistake and sees substantial upside if the company commercializes its photonics technology, monetizes its Taiwan operations, and improves its capital structure.
  • •H1 2025 revenue fell to £45.3m from £66.0m, adjusted EBITDA turned negative at -£0.4m, and adjusted net debt was £23.5m.
  • •IQE formed a partnership with Quintessent in January 2025 for quantum dot laser epitaxial wafers, with an initial $0.5m purchase order.
  • •IQE extended its multi-year strategic supply agreement with Lumentum in December 2025, validating its production-grade epitaxy capability.
  • •The company expanded its strategic review in September 2025 to include a potential sale, and is negotiating non-binding offers for the group and specific assets like the Taiwan operations.
  • •FY 2025 revenue expected at about £97m (upper end of guidance) with adjusted EBITDA of at least £2m, indicating a cyclical trough.
  • •The author lists five conditions for a potential 10x rerating: photonics as economic center, visible production-scale demand, strategic review monetization, improved operating leverage, and durable AI optical stack positioning.
Read time 12 min
Length 12,606 chars
Category finance
Ideas
Outlier Capital Substack author, Outlier Capital
The author believes IQE is undervalued by the market due to its strategic position as a materials enabler for AI photonics, despite weak near-term financials. The sell-off presents an opportunity as t
The author believes IQE is undervalued by the market due to its strategic position as a materials enabler for AI photonics, despite weak near-term financials. The sell-off presents an opportunity as the company has real ecosystem credibility, multiple partnerships (Quintessent, Lumentum), and strategic review optionality that could unlock value.
IQE HIGH
Outlier Capital Substack author, Outlier Capital
The article notes IQE's multi-year strategic supply agreement extension with Lumentum in December 2025, highlighting that Lumentum trusts IQE as a production-grade epitaxy supplier. This validates Lum
The article notes IQE's multi-year strategic supply agreement extension with Lumentum in December 2025, highlighting that Lumentum trusts IQE as a production-grade epitaxy supplier. This validates Lumentum's supply chain for advanced photonics and optical components, which are critical for AI datacenter connectivity. Risk: Lumentum's own financial performance and end-market demand for optical transceivers remain cyclical.
LITE
More from Outlier Capital
LONG 5x Stock Opportunity
Apr 24, 12:31
Portfolio Update: I’m Making Two Moves Today
Apr 23, 22:00
America Just Lit the Fuse on a Defense-and-Grid Supercycle — 5 Stocks the Market Still Doesn’t Fully Get
Apr 23, 09:39
LONG +3x Stock Opportunity
Apr 22, 12:09
LPKF Laser ($LPK): The Best Small-Cap Way to Play the Glass Packaging Supercycle?
Apr 22, 09:05

This newsletter, published April 25, 2026, features Outlier Capital discussing IQE, LITE. 2 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Outlier Capital  · Tickers: IQE, LITE